LFST

+ Watchlist + Portfolio

LifeStance Health Group, Inc.

GridBrain — Sign in

GridSentinel — Sign in

GridAegis — Sign in

Key Metrics

Previous Close: $12.83
52-Week Range: $4.77 – $12.97
Market Cap: $4.83B
P/E (TTM): 97.31
EPS (TTM): 0.13
Dividend Yield: —

Advanced Metrics

Price/Book: 3.27
PEG Ratio: —
Return on Equity: 3.43%
Return on Assets: 2.32%
Gross Margin: 33.56%
Operating Margin: 7.25%
Profit Margin: 3.19%
Current Ratio: 1.38
Debt/Equity: 0.32
Total Debt: $474.15M
Free Cash Flow: $172.36M
Revenue Growth: 26.10%
Earnings Growth: —
Enterprise Value: $5.08B

LFST Income statement, annual periods, in USD
USD	FY2022	FY2023	FY2024	FY2025
Revenue	$859.54M	$1.06B	$1.25B	$1.42B
Cost of Revenue	$622.52M	$753.57M	$848.57M	$963.19M
Gross Profit	$237.02M	$302.10M	$402.40M	$461.10M
Selling, General & Admin	$377.99M	$410.79M	$363.06M	$382.20M
Operating Expenses	$447.19M	$491.23M	$434.01M	$436.95M
Operating Income	-$210.17M	-$189.13M	-$31.61M	$24.15M
EBITDA	-$143.60M	-$104.93M	$39.87M	$78.78M
Pretax Income	-$232.73M	-$206.58M	-$57.61M	$12.36M
Income Tax	-$17.17M	-$20.32M	-$170.00K	$2.70M
Net Income	-$215.56M	-$186.26M	-$57.44M	$9.66M
Diluted EPS	-0.61	-0.51	-0.15	0.02
Diluted Shares	355.28M	367.46M	379.15M	391.14M

LFST Balance Sheet statement, annual periods, in USD
USD	FY2022	FY2023	FY2024	FY2025
Cash & Equivalents	$108.62M	$78.82M	$154.57M	$248.64M
Receivables	$101.51M	$125.64M	$132.03M	$99.50M
Current Assets	$233.22M	$225.73M	$312.51M	$416.20M
Total Assets	$2.17B	$2.11B	$2.12B	$2.20B
Current Liabilities	$176.00M	$202.87M	$228.89M	$251.96M
Long-Term Debt	$225.08M	$280.29M	$279.79M	$265.93M
Total Debt	$476.49M	$511.04M	$485.19M	$474.52M
Total Liabilities	$655.15M	$681.04M	$672.01M	$682.92M
Retained Earnings	-$572.64M	-$760.85M	-$818.29M	-$808.63M
Shareholders' Equity	$1.52B	$1.43B	$1.45B	$1.52B
Working Capital	$57.22M	$22.86M	$83.62M	$164.24M
Net Debt	$116.46M	$204.39M	$132.47M	$31.79M

LFST Cash Flow statement, annual periods, in USD
USD	FY2022	FY2023	FY2024	FY2025
Operating Cash Flow	$52.79M	-$16.88M	$107.26M	$146.15M
Capital Expenditure	-$79.25M	-$40.52M	-$21.57M	-$36.13M
Free Cash Flow	-$26.47M	-$57.40M	$85.69M	$110.03M
Depreciation & Amortisation	$69.20M	$80.44M	$70.95M	$54.75M
Stock-Based Compensation	$187.43M	$99.39M	$76.17M	$74.70M
Investing Cash Flow	-$139.46M	-$60.34M	-$21.57M	-$36.13M
Financing Cash Flow	$47.26M	$47.43M	-$9.95M	-$15.96M
Share Repurchases	$0.00	—	—	—
Net Change in Cash	-$39.41M	-$29.80M	$75.75M	$94.07M

LFST Income statement, quarterly periods, in USD
USD	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026
Revenue	$332.97M	$345.31M	$363.81M	$382.19M	$403.48M
Cost of Revenue	$223.18M	$236.88M	$247.23M	$255.90M	$267.54M
Gross Profit	$109.79M	$108.43M	$116.58M	$126.30M	$135.93M
Selling, General & Admin	$94.43M	$97.38M	$95.61M	$94.78M	$100.33M
Operating Expenses	$108.19M	$111.38M	$109.17M	$108.21M	$113.65M
Operating Income	$1.60M	-$2.95M	$7.41M	$18.08M	$22.28M
EBITDA	$15.36M	$10.96M	$20.94M	$31.51M	$34.87M
Pretax Income	-$1.47M	-$5.94M	$4.57M	$15.20M	$19.76M
Income Tax	-$2.18M	-$2.15M	$3.50M	$3.54M	$5.52M
Net Income	$709.00K	-$3.79M	$1.08M	$11.67M	$14.24M
Diluted EPS	0.00	-0.01	0.00	—	0.04
Diluted Shares	390.67M	386.73M	388.89M	—	395.08M

LFST Balance Sheet statement, quarterly periods, in USD
USD	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026
Cash & Equivalents	$134.34M	$188.93M	$203.90M	$248.64M	$194.80M
Receivables	$140.37M	$129.48M	$121.07M	$99.50M	$122.92M
Current Assets	$304.63M	$358.85M	$360.38M	$416.20M	$355.91M
Total Assets	$2.10B	$2.15B	$2.15B	$2.20B	$2.15B
Current Liabilities	$207.38M	$242.28M	$228.56M	$251.96M	$239.73M
Long-Term Debt	$276.32M	$272.86M	$269.39M	$265.93M	$262.46M
Total Debt	$473.01M	$463.37M	$460.95M	$474.52M	$458.65M
Total Liabilities	$647.57M	$672.88M	$656.23M	$682.92M	$668.47M
Retained Earnings	-$817.58M	-$821.37M	-$820.29M	-$808.63M	-$794.38M
Shareholders' Equity	$1.46B	$1.47B	$1.49B	$1.52B	$1.48B
Working Capital	$97.25M	$116.56M	$131.82M	$164.24M	$116.18M
Net Debt	$141.99M	$83.93M	$65.49M	$31.79M	$67.66M

LFST Cash Flow statement, quarterly periods, in USD
USD	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026
Operating Cash Flow	-$3.09M	$64.40M	$27.29M	$57.56M	$33.11M
Capital Expenditure	-$7.17M	-$7.75M	-$10.29M	-$10.91M	-$10.77M
Free Cash Flow	-$10.26M	$56.64M	$17.00M	$46.65M	$22.34M
Depreciation & Amortisation	$13.76M	$14.01M	$13.56M	$13.43M	$13.32M
Stock-Based Compensation	$18.58M	$21.12M	$18.30M	$16.70M	$15.20M
Investing Cash Flow	-$7.17M	-$7.75M	-$10.29M	-$10.91M	-$13.91M
Financing Cash Flow	-$9.97M	-$2.05M	-$2.02M	-$1.91M	-$73.04M
Share Repurchases	$0.00	—	—	—	-$49.11M
Net Change in Cash	-$20.23M	$54.59M	$14.97M	$44.74M	-$53.84M

Market Snapshot

About

LifeStance Health Group, Inc. is one of the largest outpatient mental health companies in the United States. The company provides mental healthcare services through a network of employed and affiliated clinicians including psychiatrists, psychologists, psychiatric nurse practitioners, and therapists. LifeStance operates in-person and virtual care centers across multiple states, offering treatment for anxiety, depression, ADHD, and other mental health conditions.